Further investigation into how candidate HERVs correlate with cytogenetic analysis and molecular markers, including NPM1 and IDH, can help refine current prognostics groups, particularly in AML patients with a normal karyotype. The gene discussed is NPM1; the disease is acute myeloid leukemia.